Ignite Creation Date:
2025-12-24 @ 11:28 PM
Ignite Modification Date:
2026-03-13 @ 8:29 AM
Study NCT ID:
NCT00720356
Status:
COMPLETED
Last Update Posted:
2018-10-26
First Post:
2008-07-19
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab and Erlotinib After Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma
Sponsor:
Northwestern University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07-07
Start Date Type:
ACTUAL
Primary Completion Date:
2014-06-24
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-05
Completion Date Type:
ACTUAL
First Submit Date:
2008-07-19
First Submit QC Date:
None
Study First Post Date:
2008-07-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-09-26
Results First Submit QC Date:
None
Results First Post Date:
2018-10-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-24
Last Update Post Date:
2018-10-26
Last Update Post Date Type:
ACTUAL